Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_assertion type Assertion NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_head.
- NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_assertion description "[drug accumulation, MDR1 P-glycoprotein (P-gp), multidrug resistance-associated protein (MRP) and topoisomerase (topo) II, to drug resistance in a large set of drug-resistant variants of the human non-small-cell lung cancer cell line SW-1573 derived by selection with low concentrations of doxorubicin or vincristine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_provenance.
- NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_assertion evidence source_evidence_literature NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_provenance.
- NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_assertion SIO_000772 7640209 NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_provenance.
- NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_assertion wasDerivedFrom befree-20150227 NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_provenance.
- NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_assertion wasGeneratedBy ECO_0000203 NP802317.RAej_pgQth1jg961K0iD-cJvIxtV3eVmuZceUvUswknIg130_provenance.